2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Minimal Hepatic Encephalopathy: new trials by email Literature Review of Minimal Hepatic Encephalopathy trials Research Report on Minimal Hepatic Encephalopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Rifaximin in Minimal Hepatic Encephalopathy Rifaximin, rifaximin - Minimal Hepatic Encephalopathy | Phase 1 / Phase 2 | Completed | Hunter Holmes Mcguire Veteran Affairs Medical Center | 20 | 2010-02-01 | 2012-12-11 |
| Probiotic Lactobacillus GG (LGG) in Patients With Minimal Hepatic Encephalopathy Lactobacillus GG, Placebo - Minimal Hepatic Encephalopathy | Phase 1 | Completed | Virginia Commonwealth University | 37 | 2009-10-01 | 2014-01-07 |
Fibrosis (2) · Hepatic Encephalopathy (1)
Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Brain Diseases (1) · Brain Diseases, Metabolic (1) · Central Nervous System Diseases (1) · Digestive System Diseases (1) · Hepatic Insufficiency (1) · Liver Diseases (1) · Liver Failure (1) · Metabolic Diseases (1) · Nervous System Diseases (1) · Nutritional and Metabolic Diseases (1)
Rifaximin (1)
Hunter Holmes Mcguire Veteran Affairs Medical Center (1) · Virginia Commonwealth University (1)
United States (2)
U01AT004428 (1)